Karagulle Erdal, Yildirim Sedat, Karakayali Feza, Turk Emin, Moray Gokhan
Department of General Surgery, Baskent University, Ankara, Turkey.
Int Surg. 2009 Oct-Dec;94(4):325-9.
We aimed to evaluate the incidence of thyroid cancer in Turkish patients with hyperthyroidism who had undergone thyroid surgery. The data of 344 patients who had been operated on for hyperthyroidism between 1998 and 2006 at our center were evaluated retrospectively. Sixty-five of the subjects had single toxic adenomas, 223 had toxic multinodular goiter, and 56 had Graves' disease. In 35 of 344 patients (10.1%), papillary carcinoma was diagnosed. Other forms of thyroid carcinomas were not observed. The rate of carcinoma was found to be 11.6% in patients with toxic multinodular goiter, 7.7% in patients with single toxic adenomas, and 7.1% in patients with Graves' disease. Occult papillary carcinoma was found in 62.9% of all malignancy diagnoses. The primary aim in the surgical treatment of hyperthyroidism should be to abolish the hyperthyroid state. However, the probability of malignancy, especially occult carcinoma, should always be considered.
我们旨在评估接受甲状腺手术的土耳其甲亢患者中甲状腺癌的发病率。回顾性评估了1998年至2006年间在我们中心接受甲亢手术的344例患者的数据。其中65例患有单发毒性腺瘤,223例患有毒性多结节性甲状腺肿,56例患有格雷夫斯病。344例患者中有35例(10.1%)被诊断为乳头状癌。未观察到其他形式的甲状腺癌。毒性多结节性甲状腺肿患者的癌发生率为11.6%,单发毒性腺瘤患者为7.7%,格雷夫斯病患者为7.1%。在所有恶性肿瘤诊断中,隐匿性乳头状癌占62.9%。甲亢手术治疗的主要目的应是消除甲亢状态。然而,应始终考虑恶性肿瘤尤其是隐匿性癌的可能性。